Japan's Takara Bio cuts coronavirus test time in half

Asia’s largest research reagent company supplies enough to test 2 million per month

20200430 Takara bio

Takara Bio has developed a new reagent which allows coronavirus infections to be determined in about an hour. © Takara Bio

Nikkei staff writers

TOKYO -- Japanese biotech company Takara Bio said Thursday it has developed a new reagent which allows coronavirus infections to be determined in about an hour, slashing the required testing time by more than half from existing methods.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.